| Net Cash Provided by (Used in) Operating Activities |
$-680,000 |
USD |
-7.94% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$31,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
150,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
3,207,399 |
shares |
199% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-649,000 |
USD |
-3.02% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,737,000 |
USD |
-33.5% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,000 |
USD |
-80% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$39,406,000 |
USD |
2.67% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$39,406,000 |
USD |
2.67% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$17,000 |
USD |
0% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
150 |
shares |
-72.5% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
11805% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$245,846,000 |
USD |
4.06% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
150 |
shares |
-72.5% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |